Clinical Trials Logo

Clinical Trial Summary

Prevalence Study evaluating the acquisition of carriage of multidrug-resistant Gram-negative bacteria (MDRGNB) in the gut flora in volunteers of French Armed Forces staying from 4 to 6 months outside France.


Clinical Trial Description

Emergence of MDRGN bacteria is blowing worldwide up leading to therapeutical failure in hospitalized patients with severe infections, as well as in outpatients with community-acquired infections such as UTI. Variation in prevalence exists across countries and regions. Travels outside own country of residence, like France, whatever the duration (short or long)or the reason (professional or leisure), are known risk factors for acquiring and disseminating MDRGN bacteria. Digestive carriage of multidrug-resistant Enterobacteriaceae could be a source of infection for the host as well as a source of dissemination. Qualitative and quantitative gut colonization by MDRGNB is poorly studied in non-hospitalized people who stayed for a few months out of France. The total amount of multidrug-resistant Enterobacteriaceae influences the spread of the dissemination. In our knowledge, no clinical study has been carried out to qualify and quantify gut colonization by MDRGNB in volunteers after staying 4-6 months outside country of residence such as France. A specific microbiological method will be evaluated in this study. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Dysbiosis
  • Intestinal Bacteria Flora Disturbance

NCT number NCT01591538
Study type Observational
Source Da Volterra
Contact
Status Completed
Phase N/A
Start date March 2012
Completion date December 2013

See also
  Status Clinical Trial Phase
Completed NCT02538211 - The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses N/A
Completed NCT02220439 - Does the Fecal Microbiome Influence Rotarix Immunogenicity N/A
Completed NCT02539836 - Study on Dietary Nutrition Intervention Techniques for Children Obesity N/A
Recruiting NCT05461508 - Fucoidan Assisted Eradication of Helicobacter Pylori Phase 1/Phase 2
Active, not recruiting NCT03667404 - Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study Phase 2
Completed NCT02318134 - Fecal Microbiota Transplantation for Pancreatitis Phase 2
Recruiting NCT04672889 - Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis N/A
Completed NCT03770143 - Evaluation of the Effect of Palm Olein Free Formula on Intestinal Flora and Gastrointestinal Tolerance
Completed NCT03103958 - Effects of Probiotic on Modulation of the Intestinal Microbiota in Constipated Patients N/A
Not yet recruiting NCT05658055 - The Effect of Probiotics on Gut Microbiotain After Helicobacter Pylori Eradication Phase 4
Recruiting NCT03016780 - Fecal Microbiota Transplantation for Ulcerative Colitis Phase 1/Phase 2
Recruiting NCT03018613 - Fecal Microbiota Transplantation for Chronic Functional Constipation Phase 1/Phase 2
Recruiting NCT03015467 - Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis(SAP) Phase 1/Phase 2
Completed NCT05016999 - Allium Extracts on the Intestinal Microbiota in Healthy Resident Volunteers. N/A
Completed NCT02377063 - The Effect of Fruit/Vegetable Drinks on the Human Intestine N/A